Pay in 4 interest-free payments of $6.13 Learn more
Ships within 48 hours · Estimated delivery Aug 6 - Aug 11
Research systematically characterising the structure-activity relationships of Thymosin Beta-4 through deletion and substitution analysis validated TB-500s sequence as the minimal active fragment retaining full biological activity and confirming that the 17 amino acid actin-binding domain peptide reproduces the wound healing, cell migration, and angiogenic effects of intact Thymosin Beta-4 in relevant assay systems
One missed dose does not derail your treatment
This product contains a 30mL multi-dose vial
Step 4: Dissolution Standard reconstitution practice is to swirl the vial gently with a slow rotating motion
Navigating Treatment A clear roadmap aids in making peptide treatment complement other care for cycle stability
US$ 29.05
US$ 29.72
US$ 23.95
US$ 28.13
.svg)
US$ 27.82
US$ 27.80
US$ 28.52
